Hyperbaric oxygen for children with cerebral palsy: a randomised multicentre trial. HBO-CP Research Group

J P Collet1, M Vanasse, P Marois

  • 1Randomised Clinical Trial Unit, Jewish General Hospital, Montreal, Quebec, Canada. jpcollet@epid.jgh.mcgill.ca

Lancet (London, England)
|September 18, 2001
PubMed

Insights

Hyperbaric oxygen therapy did not improve gross motor function or other outcomes in children with cerebral palsy compared to sham treatment. Ear problems were more common in the hyperbaric oxygen group.

Area of Science:

  • Pediatric Neurology
  • Rehabilitative Medicine
  • Oxygen Therapy

Background:

  • Hyperbaric oxygen (HBO) therapy is increasingly used for children with cerebral palsy (CP) globally.
  • Scientific evidence supporting its efficacy in CP is limited.
  • This study aimed to evaluate HBO's effectiveness and side effects in pediatric CP.

Purpose of the Study:

  • To assess the efficacy of hyperbaric oxygen therapy in improving gross motor function in children with cerebral palsy.
  • To evaluate the impact of hyperbaric oxygen on secondary outcomes, including daily living activities, attention, memory, and speech.
  • To identify and compare the side effects of hyperbaric oxygen therapy versus sham treatment in this population.

Main Methods:

  • A randomized controlled trial involving 111 children (aged 3-12 years) with cerebral palsy.
  • Participants were assigned to receive either hyperbaric oxygen (100% O2 at 1.75 ATA) or slightly pressurized room air (1.3 ATA) for 40 treatments over 2 months.
  • Outcomes included gross motor function, activities of daily living, attention, working memory, and speech.

Main Results:

  • Both hyperbaric oxygen and sham treatment groups showed improvements across all measured outcomes.
  • No statistically significant difference was observed between the hyperbaric oxygen and sham air groups for gross motor function (mean difference -0.40, p=0.544).
  • Ear problems were significantly more frequent in the hyperbaric oxygen group (27 children) compared to the sham air group (15 children, p=0.004).

Conclusions:

  • Hyperbaric oxygen therapy demonstrated no significant benefit over sham treatment for children with cerebral palsy.
  • The observed improvements in both groups warrant further investigation into the underlying mechanisms.
  • The increased incidence of ear problems highlights a potential safety concern with hyperbaric oxygen in this patient group.
Abstract